Company Filing History:
1 out of 2 
1 out of 1 
1 out of 1 
Years Active: 2013-2018
Title: Karel Vales: Innovator in Neuroprotective Compounds
Introduction
Karel Vales is a notable inventor based in Praha, Czech Republic. He has made significant contributions to the field of neuroprotective compounds, holding two patents that showcase his innovative work. His research focuses on addressing various neuropsychiatric disorders through the development of specialized compounds.
Latest Patents
Vales' latest patents include "Amphiphilic compounds with neuroprotective properties" and "Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them." The first patent details amphiphilic compounds with a tetradecahydrophenanthrene skeleton, which exhibit neuroprotective effects. These compounds are aimed at treating neuropsychiatric disorders associated with an imbalance in the glutamatergic neurotransmitter system. Conditions such as ischemic damage of the central nervous system (CNS), neurodegenerative changes, affective disorders, and various forms of pain and addiction are addressed through his innovative approach. The second patent focuses on a compound with a general formula that outlines its production and pharmaceutical applications.
Career Highlights
Throughout his career, Karel Vales has worked with esteemed institutions such as the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and the Institute of Physiology of the Czech Academy of Sciences. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Vales has collaborated with notable colleagues, including Hana Chodounska and Vojtech Kapras. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Karel Vales is a distinguished inventor whose work in neuroprotective compounds has the potential to transform treatment options for various neuropsychiatric disorders. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and improving health outcomes.